| Process economics of industrial monoclonal antibody manufacture SS Farid Journal of Chromatography B 848 (1), 8-18, 2007 | 400 | 2007 |
| Fed‐batch and perfusion culture processes: Economic, environmental, and operational feasibility under uncertainty J Pollock, SV Ho, SS Farid Biotechnology and Bioengineering, 2012 | 271 | 2012 |
| Allogeneic cell therapy bioprocess economics and optimization: Single‐use cell expansion technologies AS Simaria, S Hassan, H Varadaraju, J Rowley, K Warren, P Vanek, ... Biotechnology and bioengineering 111 (1), 69-83, 2014 | 198 | 2014 |
| Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation SS Farid, J Washbrook, NJ Titchener‐Hooker Biotechnology progress 21 (2), 486-497, 2005 | 140 | 2005 |
| Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture J Pollock, G Bolton, J Coffman, SV Ho, DG Bracewell, SS Farid Journal of Chromatography A 1284, 17-27, 2013 | 136 | 2013 |
| Shear stress analysis of mammalian cell suspensions for prediction of industrial centrifugation and its verification N Hutchinson, N Bingham, N Murrell, S Farid, M Hoare Biotechnology and bioengineering 95 (3), 483-491, 2006 | 136 | 2006 |
| Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture J Pollock, J Coffman, SV Ho, SS Farid Biotechnology progress 33 (4), 854-866, 2017 | 120 | 2017 |
| Human pluripotent stem cell‐derived products: Advances towards robust, scalable and cost‐effective manufacturing strategies MJ Jenkins, SS Farid Biotechnology journal 10 (1), 83-95, 2015 | 97 | 2015 |
| A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty AC Lim, J Washbrook, NJ Titchener‐Hooker, SS Farid Biotechnology and bioengineering 93 (4), 687-697, 2006 | 83 | 2006 |
| Established bioprocesses for producing antibodies as a basis for future planning SS Farid Cell Culture Engineering, 1-42, 2006 | 82 | 2006 |
| Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions S Hassan, AS Simaria, H Varadaraju, S Gupta, K Warren, SS Farid Regenerative medicine 10 (5), 591-609, 2015 | 75 | 2015 |
| A roadmap for cost-of-goods planning to guide economic production of cell therapy products YY Lipsitz, WD Milligan, I Fitzpatrick, E Stalmeijer, SS Farid, KY Tan, ... Cytotherapy 19 (12), 1383-1391, 2017 | 71 | 2017 |
| Industry 4.0: a vision for personalized medicine supply chains? J Branke, SS Farid, N Shah Cell and Gene Therapy Insights 2 (2), 263-270, 2016 | 68 | 2016 |
| Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma SS Farid, J Washbrook, NJ Titchener-Hooker Computers & chemical engineering 31 (9), 1141-1158, 2007 | 63 | 2007 |
| Modelling of the biopharmaceutical drug development pathway and portfolio management A Rajapakse, NJ Titchener-Hooker, SS Farid Computers & chemical engineering 29 (6), 1357-1368, 2005 | 59 | 2005 |
| Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty AC Lim, Y Zhou, J Washbrook, A Sinclair, B Fish, R Francis, ... Biotechnology progress 21 (4), 1231-1242, 2005 | 56 | 2005 |
| Impact of allogeneic stem cell manufacturing decisions on cost of goods, process robustness and reimbursement TDP Chilima, F Moncaubeig, SS Farid Biochemical engineering journal 137, 132-151, 2018 | 52 | 2018 |
| Technologies for large-scale umbilical cord-derived MSC expansion: Experimental performance and cost of goods analysis A Mizukami, TDP Chilima, MD Orellana, MA Neto, DT Covas, SS Farid, ... Biochemical Engineering Journal, 2018 | 52 | 2018 |
| Process economic drivers in industrial monoclonal antibody manufacture SS Farid Process Scale Purification of Antibodies, 445-466, 2017 | 49 | 2017 |
| Application of quality by design principles to the development and technology transfer of a major process improvement for the manufacture of a recombinant protein M Looby, N Ibarra, JJ Pierce, K Buckley, E O'Donovan, M Heenan, ... Biotechnology progress 27 (6), 1718-1729, 2011 | 49 | 2011 |
